Makaleler
104
Tümü (104)
SCI-E, SSCI, AHCI (97)
SCI-E, SSCI, AHCI, ESCI (97)
Scopus (100)
TRDizin (6)
Diğer Yayınlar (3)
17. Construction of Vasoactive Intestinal Peptide Encoding Lentiviral Gene Therapy Vector for Retinal Dystrophies
MOLECULAR THERAPY
, cilt.29, sa.4, ss.266, 2021 (SCI-Expanded, Scopus)
18. A Chemical Agent Induced Retinal Degenerative Disease Animal Model for Gene Therapy
MOLECULAR THERAPY
, cilt.29, sa.4, ss.273-274, 2021 (SCI-Expanded, Scopus)
29. Vasoactive Intestinal Peptide-mediated Gene Therapy for Diabetes
JOURNAL OF THE PANCREAS
, sa.15, ss.534, 2014 (Hakemli Dergi)
38. Tip 1 diyabetli hastalarda insulin tedavisinde ve insulin gen terapisinde güncel gelişmeler
Turkish Journal of Medical Sciences
, cilt.1, sa.5, ss.1-5, 2012 (SCI-Expanded, Scopus, TRDizin)
41. CLINICAL SIGNIFICANCE OF TRAIL AND TRAIL RECEPTORS IN PATIENTS WITH HEAD AND NECK CANCER
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
, cilt.33, sa.9, ss.1278-1284, 2011 (SCI-Expanded, Scopus)
52. IN VIVO FLUORESCENT IMAGING OF ALLOGENEIC AND XENOGENEIC ISLET GRAFTS FOLLOWING TRANSPLANTATION
IUBMB LIFE
, cilt.61, sa.3, ss.378-379, 2009 (SCI-Expanded, Scopus)
56. EXPRESSION PROFILES OF TRAIL LIGAND AND RECEPTORS IN ENDOMETRIAL CARCINOMA
IUBMB LIFE
, cilt.61, sa.3, ss.333, 2009 (SCI-Expanded, Scopus)
60. MOLECULAR PROFILE OF TUMOR NECROSIS FACTOR-RELATED APOPTOSIS INDUCING LIGAND (TRAIL) AND ITS RECEPTORS ON T CELLS IN PATIENTS WITH RHEUMATOID ARTHRITIS
IUBMB LIFE
, cilt.61, sa.3, ss.327, 2009 (SCI-Expanded, Scopus)
64. Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased survival in patients with prostate carcinoma
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
, cilt.26, sa.2, ss.158-165, 2008 (SCI-Expanded, Scopus)
67. Trail death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
, cilt.69, sa.3, ss.716-723, 2007 (SCI-Expanded, Scopus)
68. Testing the efficacy of substance P fragments as antitumor agents
DRUGS OF THE FUTURE
, cilt.32, ss.58, 2007 (SCI-Expanded, Scopus)
70. Pleiotropic functions of TNF-alpha determine distinct IKK beta-dependent hepatocellular fates in response to LPS
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
, cilt.292, sa.1, 2007 (SCI-Expanded, Scopus)
80. The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
, cilt.22, sa.4, ss.307-312, 2004 (SCI-Expanded, Scopus)
86. PTEN as a diagnostic tool for the prognosis of prostate carcinomas
INTERNATIONAL JOURNAL OF CANCER
, ss.372, 2002 (SCI-Expanded, Scopus)
87. GPx-1 regulated intracellular hydrogen peroxide level specifically modulates IKK-alpha activity
MOLECULAR BIOLOGY OF THE CELL
, cilt.12, 2001 (SCI-Expanded, Scopus)
101. ACTIVATION OF A PURKINJE-CELL SPECIFIC GENE BY HOMEOBOX PROTEINS
MOLECULAR BIOLOGY OF THE CELL
, cilt.6, ss.2000, 1995 (SCI-Expanded, Scopus)
104. Isolation of Acinetobacter lwoffi from Hens with Septicemia
Journal of Veterinary Medicine, Series B
, cilt.36, sa.1-10, ss.157-158, 1989 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
456
10. Testing the efficacy of a novel adenovirus mediated TRAIL gene therapy approach for the treatment of patients with Type 1 Diabetes.
Advances in Molecular Medicine, İstanbul, Türkiye, ss.160, (Tam Metin Bildiri)
11. Efficient adenovirus mediated TRAIL gene delivery into pancreatic islets as a model for the treatment of patients with type 1 diabetes
13th Annual Congress of European Society of Gene Therapy, Çek Cumhuriyeti, ss.74, (Tam Metin Bildiri)
12. Testing the efficacy of a novel adenovirus mediated TRAIL gene therapy approach for the treatment of patients with Type 1 Diabetes.
Advances in Molecular Medicine, İstanbul, Türkiye, ss.160, (Tam Metin Bildiri)
15. TRAIL ligand and receptor expressions are differentially upregulated in prostate carcinoma patients: a significant issue for gene therapy of advanced prostate cancer
13th Annual Congress of European Society of Gene Therapy, Çek Cumhuriyeti, ss.22, (Tam Metin Bildiri)
17. Adenovirus mediated NF-kB inhibiting strategies for the treatment of patients with type 1 diabetes
13th Annual Congress of European Society of Gene Therapy, Çek Cumhuriyeti, ss.88, (Tam Metin Bildiri)
19. . “Expression Profile of TRAIL and its Receptors in Breast Cancer patients with invasive ductal carcinoma’’ Vol. 5 (4), EJC Supement Elsevier, 2007.
14th European Cancer Conference, İspanya, ss.2136, (Özet Bildiri)
21. LentiVİP Gen Nakli Tip 1 Diyabetik Deneklerde Sistemik Enflamasyonu Baskılayarak Kan Şekerini Düşürdü
16. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 27 - 30 Ekim 2019, ss.1, (Tam Metin Bildiri)
23. LentiVİP Gen Nakli Tip 1 Diyabetik Deneklerde Sistemik Enflamasyonu Baskılayarak Kan Şekerini Düşürdü
16. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 27 - 30 Ekim 2019, ss.1, (Tam Metin Bildiri)
27. 1- Lentivirus mediated insulin promoter directed insulin gene expression is effective in suppressing postprandial glucose excursions in Type 1 diabetes
ESGCT 27th Annual Congress in collaboration with SETGyc, Barcelona, İspanya, 22 - 25 Ekim 2019, ss.1, (Tam Metin Bildiri)
28. 1- Lentivirus mediated insulin promoter directed insulin gene expression is effective in suppressing postprandial glucose excursions in Type 1 diabetes
ESGCT 27th Annual Congress in collaboration with SETGyc, Barcelona, İspanya, 22 - 25 Ekim 2019, ss.1, (Tam Metin Bildiri)
29. LentiVIP delivery suppresses systemic inflammation which results in beneficial outcome in Type 1 Diabetes
ESGCT 27th Annual Congress in collaboration with SETGyc, Barcelona, İspanya, 22 - 25 Ekim 2019, ss.1, (Tam Metin Bildiri)
31. LentiVIP delivery suppresses systemic inflammation which results in beneficial outcome in Type 1 Diabetes
ESGCT 27th Annual Congress in collaboration with SETGyc, Barcelona, İspanya, 22 - 25 Ekim 2019, ss.1, (Tam Metin Bildiri)
33. Generation of a lentiviral vector encoding vasoactive intestinal peptide for type 1 diabetes
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28, (Özet Bildiri)
34. Glucagon like peptide-1 as an antidiabetic gene therapy agent inducing transdifferantiation of pancreatic endocrine cells
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28, (Özet Bildiri)
35. A practical method for production and purification of 3rd generation HIV based lentiviral vectors for In vivo applications
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28, (Özet Bildiri)
36. Multiple low-dose streptozotocin injections induced diabetes in Wistar rats characterised by insulitis and hyperglycaemia useful for gene transfer studies
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28, (Özet Bildiri)
37. Development of a gene therapy vector to provide insulin expression from induced pluripotent stem cells
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28, (Özet Bildiri)
38. Generation of a beta cell specific insulin gene therapy vector for diabetes
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28, (Özet Bildiri)
39. Development of MODY10 diabetic experimental animal model using CRISPR/Cas9 technology for insulin gene transfer studies
European-Society-of-Gene-and-Cell-Therapy (ESCGT) Congress, Berlin, Almanya, 01 Ocak 2017, cilt.28, (Özet Bildiri)
43. Tip 1 diyabet için vazoaktif intestinal peptidi kodlayan lentiviral vektörün geliştirilmesi.
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, (Tam Metin Bildiri)
44. 3. jenerasyon HIV tabanli lentiviral vektörlerin ın vivo uygulamalar için u¨retimi ve pu¨rifikasyon yöntemlerinin optimizasyonu
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, ss.10, (Tam Metin Bildiri)
47. Diyabet hastalığına karşı kullanılmak üzere beta hücre spesifik gen tedavi vektörünun oluşturulması
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, ss.1, (Tam Metin Bildiri)
48. 3. jenerasyon HIV tabanli lentiviral vektörlerin ın vivo uygulamalar için üretimi ve pürifikasyon yöntemlerinin optimizasyonu
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, ss.10, (Tam Metin Bildiri)
50. Diyabet hastalığına karşı kullanılmak üzere beta hücre spesifik gen tedavi vektörünun oluşturulması
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 Ekim - 29 Kasım 2017, ss.8, (Tam Metin Bildiri)
51. Tip 1 diyabet için vazoaktif intestinal peptidi kodlayan lentiviral vektöru¨n geliştirilmesi.
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, (Tam Metin Bildiri)
52. Diyabet hastalığına karşı kullanılmak u¨zere beta hu¨cre spesifik gen tedavi vektöru¨nu¨n oluşturulması
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 Ekim - 29 Kasım 2017, ss.8, (Tam Metin Bildiri)
54. Tip 1 diyabet için vazoaktif intestinal peptidi kodlayan lentiviral vektörün geliştirilmesi
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, ss.1, (Tam Metin Bildiri)
55. İnsulin gen replasman tedavisinde kullanılmak üzere CRISPR- Cas9 yöntemiyle MODY10 diyabetik deney hayvan modeli oluşturma
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, ss.12, (Tam Metin Bildiri)
58. İnsulin gen replasman tedavisinde kullanılmak u¨zere CRISPR- Cas9 yöntemiyle MODY10 diyabetik deney hayvan modeli oluşturma
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, ss.12, (Tam Metin Bildiri)
60. 3. jenerasyon HIV tabanli lentiviral vektörlerin ın vivo uygulamalar için u¨retimi ve pu¨rifikasyon yöntemlerinin optimizasyonu
15. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 26 - 29 Ekim 2017, (Tam Metin Bildiri)
63. Generation of a beta cell specific insulin gene therapy vector for diabetes
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 Ekim - 20 Kasım 2017, ss.341, (Tam Metin Bildiri)
64. A practical method for production and purification of 3rd generation HIV based lentiviral vectors for In vivo applications
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.176, (Tam Metin Bildiri)
65. Development of MODY10 diabetic experimental animal model using CRISPR/Cas9 technology for insulin gene transfer studies
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.112, (Tam Metin Bildiri)
66. Generation of a lentiviral vector encoding vasoactive intestinal peptide for type 1 diabetes
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.152, (Tam Metin Bildiri)
69. Generation of a beta cell specific insulin gene therapy vector for diabetes", ESGCT XXV Anniversary Congress
European Society of Gene and Cell Therapy (ESGCT) XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.1, (Tam Metin Bildiri)
70. Multiple low-dose streptozotocin injections induced diabetes in Wistar rats characterised by insulitis and hyperglycaemia useful for gene transfer studies
European Society of Gene and Cell Therapy (ESGCT) ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 21 Ekim 2017, ss.1, (Tam Metin Bildiri)
71. A practical method for production and purification of 3rd generation HIV based lentiviral vectors for In vivo applications
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.176, (Tam Metin Bildiri)
72. Development of MODY10 diabetic experimental animal model using CRISPR/Cas9 technology for insulin gene transfer studies
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.112, (Tam Metin Bildiri)
73. Multiple low-dose streptozotocin injections induced diabetes in Wistar rats characterised by insulitis and hyperglycaemia useful for gene transfer studies
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 21 Ekim 2017, ss.113, (Tam Metin Bildiri)
74. Multiple low-dose streptozotocin injections induced diabetes in Wistar rats characterised by insulitis and hyperglycaemia useful for gene transfer studies
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 21 Ekim 2017, ss.113, (Tam Metin Bildiri)
75. Generation of a lentiviral vector encoding vasoactive intestinal peptide for type 1 diabetes
European Society of Gene and Cell Therapy (ESGCT) XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.1, (Tam Metin Bildiri)
76. Generation of a beta cell specific insulin gene therapy vector for diabetes
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 Ekim - 20 Kasım 2017, ss.341, (Tam Metin Bildiri)
77. Generation of a lentiviral vector encoding vasoactive intestinal peptide for type 1 diabetes
ESGCT XXV Anniversary Congress, Berlin, Almanya, 17 - 20 Ekim 2017, ss.152, (Tam Metin Bildiri)
79. Diyabet hastalığına karşı geliştirilen gen tedavi stratejilerinde kullanılmak üzere Tip 1 Diyabet hayvan modelinin oluşturulması
53. Ulusal Diyabet Kongresi, Girne, Kıbrıs (Kktc), 19 - 23 Nisan 2017, ss.1, (Tam Metin Bildiri)
83. İnkretin gen nakli diyabetik deneklerde insülin direncini kırıp glukoz toleransını geliştirerek beta hücre rejenerasyonu sağlar
53. Ulusal Diyabet Kongresi, Girne, Kıbrıs (Kktc), 19 - 23 Nisan 2017, ss.250, (Özet Bildiri)
84. Diyabet hastalığına karşı geliştirilen gen tedavi stratejilerinde kullanılmak üzere Tip 1 Diyabet hayvan modelinin oluşturulması
53. Ulusal Diyabet Kongresi, Girne, Türkiye, 19 - 23 Nisan 2017, ss.11, (Tam Metin Bildiri)
86. Diyabet Hastalığına karşı geliştirilen gen tedavi stratejilerinde kullanılmak üzere tip 1 diyabet hayvan modelinin oluşturulması
53. Ulusal Diyabet Kongresi, Girne, Kıbrıs (Kktc), 19 - 23 Nisan 2017, ss.251, (Özet Bildiri)
90. Diyabet tedavisinde in vivo gen nakil uygulamalarına uygun ölçekte ve kalitede lentiviral vektör üretimi
53. Ulusal Diyabet Kongresi., Girne, Türkiye, 19 - 23 Nisan 2017, ss.6, (Tam Metin Bildiri)
91. İnkretin gen nakli diyabetik deneklerde insülin direncini kırıp glukoz toleransını geliştirerek beta hücre rejenerasyonu sağlar
53. Ulusal Diyabet Kongresi, Girne, Türkiye, 19 - 23 Nisan 2017, ss.10, (Tam Metin Bildiri)
92. Diyabet Hastalığına karşı geliştirilen gen tedavi stratejilerinde kullanılmak üzere tip 1 diyabet hayvan modelinin oluşturulması
53. Ulusal Diyabet Kongresi, Girne, Kıbrıs (Kktc), 19 - 23 Nisan 2017, ss.251, (Özet Bildiri)
95. Diyabet hastalığına karşı geliştirilen gen tedavi stratejilerinde kullanılmak üzere Tip 1 Diyabet hayvan modelinin oluşturulması
53. Ulusal Diyabet Kongresi, Girne, Türkiye, 19 - 23 Nisan 2017, ss.11, (Tam Metin Bildiri)
96. Diyabette insülin gen tedavi stratejileri
53. Ulusal Diyabet Kongresi, Girne, Türkiye, 19 - 23 Nisan 2017, ss.117-118, (Tam Metin Bildiri)
97. Glucagon like peptide-1 gene delivery increases beta cell replication and neogenesis in Type 2 Diabetic Obese Sprague Dawley Rats
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, İtalya, 18 - 21 Ekim 2016, cilt.27, (Özet Bildiri)
98. Generation of a lentiviral vector encoding human insulin for diabetes treatment
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, İtalya, 18 - 21 Ekim 2016, cilt.27, (Özet Bildiri)
99. Novel approaches for insulin mediated gene delivery in diabetes treatment
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy, Florence, İtalya, 18 - 21 Ekim 2016, cilt.27, (Özet Bildiri)
100. Glucagon like peptide-1 gene delivery increases beta cell replication and neogenesis in Type 2 Diabetic Obese Sprague Dawley Rats
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy., Floransa, İtalya, 18 - 21 Ekim 2016, cilt.27, sa.11, (Tam Metin Bildiri)
101. Glucagon like peptide-1 gene delivery increases beta cell replication and neogenesis in Type 2 Diabetic Obese Sprague Dawley Rats
Conference on Changing the Face of Modern Medicine - Stem Cells and Gene Therapy., Floransa, İtalya, 18 - 21 Ekim 2016, cilt.27, sa.11, (Tam Metin Bildiri)
102. Pankreatik beta hücre hedefli HİV tabanlı insülin gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.206, (Tam Metin Bildiri)
103. Diyabet Tedavisinde inkretin tabanlı gen tedavi stratejileri.
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.67-68, (Tam Metin Bildiri)
104. EF-1 promotoru kontrolünde insulin gen ekspresyonu yapan HİV tabanlı lentiviral gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.200, (Tam Metin Bildiri)
105. EF-1 promotoru kontrolünde insulin gen ekspresyonu yapan HİV tabanlı lentiviral gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.200, (Tam Metin Bildiri)
106. Pankreatik beta hücre hedefli HİV tabanlı insülin gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.206, (Tam Metin Bildiri)
107. EF-1 promotoru kontrolünde insulin gen ekspresyonu yapan HİV tabanlı lentiviral gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.200, (Tam Metin Bildiri)
108. EF-1 promotoru kontrolünde insulin gen ekspresyonu yapan HİV tabanlı lentiviral gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.200, (Tam Metin Bildiri)
109. Pankreatik beta hücre hedefli HİV tabanlı insülin gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.206, (Tam Metin Bildiri)
110. Pankreatik beta hücre hedefli HİV tabanlı insülin gen tedavi vektörünün oluşturulması
Uluslararası Katılımlı 12. Ulusal Tıbbi Genetik Kongresi, İzmir, Türkiye, 5 - 09 Ekim 2016, cilt.2, ss.206, (Tam Metin Bildiri)
112. 3. Jenerasyon Lentivirus aracılı Vazoaktif İntestinal Peptid gen naklinin obezite bağımlı Tip 2 Diyabet deney hayvan modelinde terapötik etkinliği
14. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Türkiye, 27 - 30 Ekim 2015, (Tam Metin Bildiri)
117. Vasoactive intestinal peptide gene delivery for diabetes treatment
Molecular Biologu and Genetics Congress, İstanbul, Türkiye, 2 - 04 Ekim 2015, ss.10, (Özet Bildiri)
118. Vasoactive intestinal peptide gene delivery for diabetes treatment
Molecular Biologu and Genetics Congress, İstanbul, Türkiye, 2 - 04 Ekim 2015, ss.10, (Özet Bildiri)
119. Obese and diabetic sprague dawley rats exhibited reduced GLP-1 expression in pancreatic islets of Langerhans
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finlandiya, 17 - 20 Eylül 2015, cilt.26, (Özet Bildiri)
120. In vivo distribution of HIV based 3rd generation of lentiviral vectors used in gene therapy in DOI animal model of type 2 diabetes
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finlandiya, 17 - 20 Eylül 2015, cilt.26, (Özet Bildiri)
121. Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy (ESGCT) and Finnish-Society-of-Gene-Therapy (FSGT), Helsinki, Finlandiya, 17 - 20 Eylül 2015, cilt.26, (Özet Bildiri)
122. In vivo distribution of HIV based 3rd generation of lentiviral vectors used in gene therapy in DOI animal model of type 2 diabetes
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finlandiya, 17 - 20 Eylül 2015, (Tam Metin Bildiri)
123. Obese and diabetic sprague dawley rats exhibited reduced GLP-1 expression in pancreatic islets of Langerhans
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finlandiya, 17 - 20 Eylül 2015, (Tam Metin Bildiri)
124. In vivo distribution of HIV based 3rd generation of lentiviral vectors used in gene therapy in DOI animal model of type 2 diabetes
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finlandiya, 17 - 20 Eylül 2015, (Tam Metin Bildiri)
125. In vivo distribution of HIV based 3rd generation of lentiviral vectors used in gene therapy in DOI animal model of type 2 diabetes
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finlandiya, 17 - 20 Eylül 2015, (Tam Metin Bildiri)
126. Obese and diabetic sprague dawley rats exhibited reduced GLP-1 expression in pancreatic islets of Langerhans
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finlandiya, 17 - 20 Eylül 2015, (Tam Metin Bildiri)
127. Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment
ESGCT and FSGCT Collaborative Congress, Helsinki, Finlandiya, 17 - 20 Eylül 2015, (Tam Metin Bildiri)
128. In vivo distribution of HIV based 3rd generation of lentiviral vectors used in gene therapy in DOI animal model of type 2 diabetes
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finlandiya, 17 - 20 Eylül 2015, (Tam Metin Bildiri)
129. Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment
ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finlandiya, 17 - 20 Eylül 2015, (Tam Metin Bildiri)
130. Diyabet tedavisi için insan Glukagon Benzeri Peptid-1 kodlayan lentiviral vektörlerin üretimi
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, (Özet Bildiri)
131. Diyet bağımlı obez Sprague Dawley sıçanlarda STZ ile diyabet indüksiyonu pankreatik adacıklarda inkretin hormonu (GLP-1) sentezini azaltır
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.146, (Özet Bildiri)
132. Gen tedavisinde kullanılan lentivlral vektörlerin in vivo dağılımlarının Tip 2 Diyabet hayvan modelinde belirlenmesi
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.146-147, (Özet Bildiri)
133. Gen tedavisinde kullanılan lentivlral vektörlerin in vivo dağılımlarının Tip 2 Diyabet hayvan modelinde belirlenmesi
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.146-147, (Özet Bildiri)
134. HİV tabanlı Lentivirus aracılı Vazoaktif İntestinal Peptid gen nakli obez farelerde insulin direncini kırıp glukoz toleransı geliştirerek STZ indüklü diyabet gelişimini durdurdu
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, (Tam Metin Bildiri)
135. Diyabet tedavisi için insan Glukagon Benzeri Peptid-1 kodlayan lentiviral vektörlerin üretimi
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, (Özet Bildiri)
136. Diyet bağımlı obez Sprague Dawley sıçanlarda STZ ile diyabet indüksiyonu pankreatik adacıklarda inkretin hormonu (GLP-1) sentezini azaltır
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.146, (Özet Bildiri)
137. Gen tedavisinde kullanılan lentivlral vektörlerin in vivo dağılımlarının Tip 2 Diyabet hayvan modelinde belirlenmesi
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.146-147, (Özet Bildiri)
138. Gen tedavisinde kullanılan lentivlral vektörlerin in vivo dağılımlarının Tip 2 Diyabet hayvan modelinde belirlenmesi
51. Ulusal Diyabet Kongresi, Antalya, Türkiye, 22 - 26 Nisan 2015, ss.146-147, (Özet Bildiri)
139. Construction of A lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
EMBO Workshop, Evry, Fransa, 30 Mart - 04 Nisan 2015, ss.185, (Tam Metin Bildiri)
140. Construction of A lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
EMBO Workshop, Evry, Fransa, 30 Mart - 04 Nisan 2015, ss.185, (Tam Metin Bildiri)
141. Construction of A lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
EMBO Workshop, Evry, Fransa, 30 Mart - 04 Nisan 2015, ss.185, (Tam Metin Bildiri)
142. Construction of A lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
EMBO Workshop, Evry, Fransa, 30 Mart - 04 Nisan 2015, ss.185, (Tam Metin Bildiri)
143. Comparative efficacy of diet induced obesity in C57BL/6J versus Balb/C mice for gene therapy applications
ESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, cilt.25, (Özet Bildiri)
144. Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
ESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, cilt.25, (Özet Bildiri)
145. Induction of Diet Induced Obesity in Sprague Dawley Rats as a Model for Type 2 Diabetes
ESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, cilt.25, (Özet Bildiri)
146. Up-regulation of Glucagon Like Peptide-1 Expression in pancreases of C57BL6J Mice with Diabetes
ESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, cilt.25, (Özet Bildiri)
148. Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
ESGCT AND NVGCT COLLABORATIVE CONGRESS, 2014, The Hauge, Amsterdam, Hollanda, 23 - 26 Ekim 2014, cilt.25, sa.11, ss.87-88, (Tam Metin Bildiri)
149. Induction of Diet İnduced Obesity in Sprague Dawley Rats as a Model of Type 2 Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014, (Tam Metin Bildiri)
150. Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123, (Tam Metin Bildiri)
151. Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123, (Tam Metin Bildiri)
152. Therapeutic efficacy of an HIV-Based Lentivirus Mediated Vasoactive İntestinal Peptide Gene Delivery for Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014, (Özet Bildiri)
153. Up Regulation of Glukagon Like Peptide-1 Expression in Pancreases of C57BL6j Mice with Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014, (Tam Metin Bildiri)
154. Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
ESGCT AND NVGCT COLLABORATIVE CONGRESS, 2014, The Hauge, Amsterdam, Hollanda, 23 - 26 Ekim 2014, cilt.25, sa.11, ss.87-88, (Tam Metin Bildiri)
155. Therapeutic efficacy of an HIV-Based Lentivirus Mediated Vasoactive İntestinal Peptide Gene Delivery for Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014, (Özet Bildiri)
156. Up Regulation of Glukagon Like Peptide-1 Expression in Pancreases of C57BL6j Mice with Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014, (Tam Metin Bildiri)
158. Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
ESGCT AND NVGCT COLLABORATIVE CONGRESS, 2014, The Hauge, Amsterdam, Hollanda, 23 - 26 Ekim 2014, cilt.25, sa.11, ss.87-88, (Tam Metin Bildiri)
159. Comperative efficacy of Diet İnduced Obesity in c57bl/6j versus Balb/C mice for gene Threapy applications
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014, (Tam Metin Bildiri)
160. Therapeutic efficacy of an HIV-Based Lentivirus Mediated Vasoactive İntestinal Peptide Gene Delivery for Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014, (Özet Bildiri)
161. Induction of Diet İnduced Obesity in Sprague Dawley Rats as a Model of Type 2 Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014, (Tam Metin Bildiri)
163. Up Regulation of Glucagon Like Peptide-1 Expression in Pancreases of C57BL6j Mice with Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014, (Tam Metin Bildiri)
164. Generation of A Lentiviral Vector Encoding Human Glucagon Like Peptide-1 (GLP-1) for Diabetes Treatment
ESGCT AND NVGCT COLLABORATIVE CONGRESS, 2014, The Hauge, Amsterdam, Hollanda, 23 - 26 Ekim 2014, cilt.25, sa.11, ss.87-88, (Tam Metin Bildiri)
165. Comperative efficacy of Diet İnduced Obesity in c57bl/6j versus Balb/C mice for gene Threapy applications
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014, (Tam Metin Bildiri)
167. Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123, (Tam Metin Bildiri)
168. Comperative efficacy of Diet İnduced Obesity in c57bl/6j versus Balb/C mice for gene Threapy applications
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014, (Tam Metin Bildiri)
169. Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123, (Tam Metin Bildiri)
170. Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 14 - 17 Haziran 2014, ss.659, (Tam Metin Bildiri)
171. Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 14 - 17 Haziran 2014, ss.659, (Tam Metin Bildiri)
172. Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 14 - 17 Haziran 2014, ss.659, (Tam Metin Bildiri)
173. Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 14 - 17 Haziran 2014, ss.659, (Tam Metin Bildiri)
174. Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 13 - 17 Haziran 2014, cilt.63, (Tam Metin Bildiri)
175. Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 13 - 17 Haziran 2014, cilt.63, (Tam Metin Bildiri)
176. Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 13 - 17 Haziran 2014, cilt.63, (Tam Metin Bildiri)
177. Constitution of Pre-diabetic State in C57BL6J Mice Versus Sprague Dawley Rats
American Diabetes Association, San Francisco, Amerika Birleşik Devletleri, 13 - 17 Haziran 2014, cilt.63, (Tam Metin Bildiri)
178. Restoration of Pancreatic Beta Cell Mass and Function by GLP-1 Gene Delivery for Diabetes
Beta Cells in Health and Disease, Kocaeli, Türkiye, 21 - 23 Mayıs 2014, ss.1, (Tam Metin Bildiri)
179. Diyabet hastalığına karşı geliştirilen insan vazoaktif intestinal peptid kodlayan HİV tabanlı gen transfer vektörlerinin yapımı ve testi
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.12, (Özet Bildiri)
181. C57BL6J FARELERDE DİYABET İNDÜKSİYONU PANKREAS KÖKENLİ GLP-1 SENTEZİNİ ARTTIRDI
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.166, (Özet Bildiri)
185. C57BL6J FARELERDE DİYABET İNDÜKSİYONU PANKREAS KÖKENLİ GLP-1 SENTEZİNİ ARTTIRDI
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.166, (Özet Bildiri)
186. Diyabet hastalığına karşı geliştirilen insan vazoaktif intestinal peptid kodlayan HİV tabanlı gen transfer vektörlerinin yapımı ve testi
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.12, (Özet Bildiri)
188. C57BL6J FARELERDE DİYABET İNDÜKSİYONU PANKREAS KÖKENLİ GLP-1 SENTEZİNİ ARTTIRDI
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.166, (Özet Bildiri)
189. Diyabet tedavisinde inkretin tabanlı gen transfer stratejilerinin yeri
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, (Tam Metin Bildiri)
190. C57BL6J FARELERDE DİYABET İNDÜKSİYONU PANKREAS KÖKENLİ GLP-1 SENTEZİNİ ARTTIRDI
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.166, (Özet Bildiri)
191. Diyabet hastalığına karşı geliştirilen insan vazoaktif intestinal peptid kodlayan HİV tabanlı gen transfer vektörlerinin yapımı ve testi
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.12, (Özet Bildiri)
192. Diyabet hastalığına karşı geliştirilen insan vazoaktif intestinal peptid kodlayan HİV tabanlı gen transfer vektörlerinin yapımı ve testi
50. Ulusal Diyabet Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2014, ss.12, (Özet Bildiri)
193. GLP-1 and GLP-1-receptor expression profiles in pancreatic islets of Diet Induced Obese (DIO) Mice
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish-Society-for-Gene-and-Cell-Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, (Özet Bildiri)
194. Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138, (Tam Metin Bildiri)
195. Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138, (Tam Metin Bildiri)
196. Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138, (Tam Metin Bildiri)
198. Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138, (Tam Metin Bildiri)
201. Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes
Congress of American Diabetes Association, Chicago, Amerika Birleşik Devletleri, 21 - 25 Haziran 2013, cilt.62, ss.2258, (Özet Bildiri)
202. Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes
Congress of American Diabetes Association, Chicago, Amerika Birleşik Devletleri, 21 - 25 Haziran 2013, cilt.62, ss.2258, (Özet Bildiri)
203. Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes
Congress of American Diabetes Association, Chicago, Amerika Birleşik Devletleri, 21 - 25 Haziran 2013, cilt.62, ss.2258, (Özet Bildiri)
204. Diyabette Vazoaktif Intestinal Peptidin terapotik rolü
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.12, (Özet Bildiri)
205. Diyabette Vazoaktif Intestinal Peptidin terapotik rolü
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.12, (Özet Bildiri)
206. Tip 2 diyabet deney hayvan modelinde diyabet induksiyonu adaciklarda vazoaktif intestinal peptid azalimiyla korelasyon gosterdi
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.20, (Özet Bildiri)
207. Tip 2 diyabet deney hayvan modelinde diyabet induksiyonu adaciklarda vazoaktif intestinal peptid azalimiyla korelasyon gosterdi
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.20, (Özet Bildiri)
208. Tip 2 diyabet deney hayvan modelinde diyabet induksiyonu adaciklarda vazoaktif intestinal peptid azalimiyla korelasyon gosterdi
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.20, (Özet Bildiri)
209. Tip 2 diyabet deney hayvan modelinde diyabet induksiyonu adaciklarda vazoaktif intestinal peptid azalimiyla korelasyon gosterdi
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.20, (Özet Bildiri)
210. Generation of a cost effective and a practical animal model for Type 2 Diabetes
Collaborative Congress of the European Society of Gene and Cell Therapy/French Society of Cell and Gene Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, sa.10, ss.78-79, (Özet Bildiri)
213. Generation of a cost effective and a practical animal model for Type 2 Diabetes
Collaborative Congress of the European Society of Gene and Cell Therapy/French Society of Cell and Gene Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, sa.10, ss.78-79, (Özet Bildiri)
216. Generation of a cost effective and a practical animal model for Type 2 Diabetes
Collaborative Congress of the European Society of Gene and Cell Therapy/French Society of Cell and Gene Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, sa.10, ss.78-79, (Özet Bildiri)
217. Generation of a cost effective and a practical animal model for Type 2 Diabetes
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, (Özet Bildiri)
218. Pancreatic acinar cells respond differentially to diabetic agents Streptozotocin and Cyclophosphamide
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, (Özet Bildiri)
219. Multiple Myeloma Patients Display Decreased Death Ligand Expression on T Lymphocytes
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, (Özet Bildiri)
220. Potential Therapeutic Role of Vasoactive Intestinal Peptide in Diabetes
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, (Özet Bildiri)
221. The efficacy of insulin gene therapy in autoimmune diabetes
Molecular Immunology & Immunogenetics Congress, Antalya, Türkiye, 27 - 29 Nisan 2012, ss.49-50, (Özet Bildiri)
225. Rexin G, the first and the only targetted gene delivery vehicle developed to seek out and destroy metastatic cancer cell to date
XII Ulusal Tibbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 27 - 30 Ekim 2011, ss.15, (Özet Bildiri)
228. NOD farelerde streptozotosin veye siklofosfamid ile hizlandirilmis Tip 1 Diyabet gelisim surecinde pankreatik asinar hucrelerde farkli TRAIL ligand ve reseptor paternleri
XII Ulusal Tibbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 27 - 30 Ekim 2011, ss.187, (Özet Bildiri)
229. Rexin G, the first and the only targetted gene delivery vehicle developed to seek out and destroy metastatic cancer cell to date
XII Ulusal Tibbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 27 - 30 Ekim 2011, ss.15, (Özet Bildiri)
231. Tip 1 Diyabette gen ve hucre tedavisinin yeri
Turkiye Endokrinoloji ve Metabolizma Hastaliklari Kongresi, Antalya, Türkiye, 12 - 16 Ekim 2011, ss.33, (Özet Bildiri)
232. Clinical genetic significance of TRAIL and TRAIL receptors in patients with head and neck cancer
9th National Medical Genetics Congress, İstanbul, Türkiye, 1 - 05 Aralık 2010, ss.59, (Özet Bildiri)
233. Clinical genetic significance of TRAIL and TRAIL receptors in patients with head and neck cancer
9th National Medical Genetics Congress, İstanbul, Türkiye, 1 - 05 Aralık 2010, ss.59, (Özet Bildiri)
234. “In Vivo Fluorescence Tracing Of Xenogeneic Islet Graft Survival In Type 1 Diabetes
9th National Congress of Medical Genetics, İstanbul, Türkiye, 1 - 05 Aralık 2010, cilt.0, sa.0, ss.1-2, (Özet Bildiri)
235. In vivo fluorescence tracing of xenogeneic islet graft survival in Type 1 Diabetes
9th National Medical Genetics Congress, İstanbul, Türkiye, 1 - 05 Aralık 2010, ss.129, (Özet Bildiri)
244. TRAIL expression significantly decreases in CY-accelerated type 1 diabetes in NOD mice
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1453-1454, (Özet Bildiri)
245. Trail profile of synoviocytes and peripheral blood lymphocytes of rheumatoid arthritis patients
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1448-1449, (Özet Bildiri)
246. Distinctive expression profiles of trail and trail receptors in patients with endometrial carcinoma
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1462, (Özet Bildiri)
247. Spontaneous type 1 diabetes in NOD mice is related to an increase in DcR1 expression
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1447-1448, (Özet Bildiri)
248. The importance of sTRAIL in patients with rheumatoid arthritis
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1461, (Özet Bildiri)
249. In vivo fluorescence imaging of xenogeneic islet graft survival
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1451, (Özet Bildiri)
250. The outcome of trail presentation on T cells in patients with multiple myeloma
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1462, (Özet Bildiri)
251. Endometrial hyperplasia features distinctive trail and trail receptor expression profiles
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1462-1463, (Özet Bildiri)
252. STZ administration leads to a significant rise in TRAIL and DcR1 levels in Non-Obese Diabetic (NOD)
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1453, (Özet Bildiri)
254. Non-obese diabetic (NOD) farelerde streptozotosin veya siklofosfamid ile indüklenen diyabette T1D’in moleküler patogenezinin aydınlatılmasına yönelik bulgular
46. Ulusal Diyabet Kongresi, Antalya, Türkiye, 12 - 16 Mayıs 2010, ss.6, (Özet Bildiri)
258. Adenovirus mediated TRAIL gene therapy approach provides sustained insulin expression in STZ-induced diabetic rats
17th Annual Congress of the European Society of Gene & Cell Therapy, Hannover, Almanya, 21 - 25 Kasım 2009, ss.1471-1472, (Tam Metin Bildiri)
259. Adenovirus mediated TRAIL gene therapy approach provides sustained insulin expression in STZ-induced diabetic rats
17th Annual Congress of the European Society of Gene & Cell Therapy, Hannover, Almanya, 21 - 25 Kasım 2009, ss.1471-1472, (Tam Metin Bildiri)
260. TRAIL death receptor-4 and decoy receptors expression on CD8+T cells correlate with the disease severity in rheumatoid arthritis patients p.149, Nov 21-25, 2009, 2009 Hannover, Germany. Human Gene Therapy 2009; 20 (11): 1471-1471
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research,, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1471, (Tam Metin Bildiri)
261. Tracing of the fate of allogeneic islet grafts via CCD camera
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1479, (Özet Bildiri)
262. Differential levels of TRAIL ligand and receptor expressions in STZ-induced T1 diabetes in non-obese diabetic (NOD) mice
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1483, (Özet Bildiri)
263. TRAIL death receptor-4 and decoy receptors expression on CD8+T cells correlate with the disease severity in rheumatoid arthritis patients
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1471, (Özet Bildiri)
264. Monitoring of systemic delivery of adenovirus mediated EGFP transgene expression in mice using fluorescence imaging
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1507, (Özet Bildiri)
265. Distinctive expression profile of TRAIL and TRAIL receptors in patients with head and neck cancer
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1422-1423, (Özet Bildiri)
266. Adenovirus mediated TRAIL gene therapy approach provides sustained insulin expression in STZ-induced diabetic rats
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1471-1472, (Özet Bildiri)
267. Diagnostic significance of serum sTRAIL in rheumatoid arthritis
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1494, (Özet Bildiri)
269. Alterations in TRAIL ligand and receptor expression profiles in CY-accelerated type 1 diabetes in NOD mice
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1483, (Özet Bildiri)
270. Prospective cell and gene therapy approaches designed to extend islet graft survival in patients with type 1 diabetes
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1482-1483, (Özet Bildiri)
271. In vivo fluorescence imaging as a method to assess pancreatic islet xenograft failure
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1479, (Özet Bildiri)
280. TRAİL ve reseptörlerinin yassı hücreli larenks ve oral kavite kanserleriyle ilişkisi
31. Ulusal Kulak Burun Bogaz ve Bas ve Boyun Cerrahisi Kongresi, Antalya, Türkiye, 28 Ekim - 01 Kasım 2009, ss.34, (Özet Bildiri)
281. TRAİL ve reseptörlerinin yassı hücreli larenks ve oral kavite kanserleriyle ilişkisi
31. Ulusal Kulak Burun Bogaz ve Bas ve Boyun Cerrahisi Kongresi, Antalya, Türkiye, 28 Ekim - 01 Kasım 2009, ss.34, (Özet Bildiri)
284. Rheumatoid Arthritis disease activity is correlated with TRAIL death receptor-4 and decoy receptor expresions on CD8+T cells
34th Congress of the Federation-of-European-Biochemical-Societies, Prague, Çek Cumhuriyeti, 4 - 09 Temmuz 2009, cilt.276, ss.259, (Özet Bildiri)
285. Increased serum sTRAIL level following BevacizumAb treatment is correlated with patient survival in metastatic colon cancer
34th Congress of the Federation-of-European-Biochemical-Societies, Prague, Çek Cumhuriyeti, 4 - 09 Temmuz 2009, cilt.276, ss.301-302, (Özet Bildiri)
289. Serum s TRAIL us efor the assessment of the efficacy of BevacizumAb treatment in metastatic colon cancer
1st International Multidisciplinary Cancer Research Congress, Antalya, Türkiye, 21 - 24 Mayıs 2009, ss.8, (Tam Metin Bildiri)
290. Tip 1 diyabette alloimmune mononüklear hücre infiltrasyonun gen tedavisiyle baskılanması fonksiyonel adacık-graft ömrünü uzatır
45. Ulusal Diyabet Kongresi, Antalya, Türkiye, 20 - 24 Mayıs 2009, ss.56, (Özet Bildiri)
291. Tip 1 diyabette alloimmune mononüklear hücre infiltrasyonun gen tedavisiyle baskılanması fonksiyonel adacık-graft ömrünü uzatır
45. Ulusal Diyabet Kongresi, Antalya, Türkiye, 20 - 24 Mayıs 2009, ss.56, (Özet Bildiri)
292. Diyabetik farelere sıçan pankreatik adacıklarının ksenotransplantasyonu normoglisemi sağlamaktadır
45. Ulusal Diyabet Kongresi, Antalya, Türkiye, 20 - 24 Mayıs 2009, ss.76, (Özet Bildiri)
293. Diyabetik farelere sıçan pankreatik adacıklarının ksenotransplantasyonu normoglisemi sağlamaktadır
45. Ulusal Diyabet Kongresi, Antalya, Türkiye, 20 - 24 Mayıs 2009, ss.76, (Özet Bildiri)
294. Highlights in the molecular pathogenesis of type 1 diabetes
3rd International Congress of Molecular Medicine, İstanbul, Türkiye, 5 - 08 Mayıs 2009, ss.324-325, (Özet Bildiri)
295. Highlights in the molecular pathogenesis of type 1 diabetes
3rd International Congress of Molecular Medicine, İstanbul, Türkiye, 5 - 08 Mayıs 2009, ss.324-325, (Özet Bildiri)
298. A novel gene therapy strategy involving immune-modulation relinquished lymphocyte infiltration into islet grafted sites in STZ induced diabetic rats
11th European Congress of Endocrinology, İstanbul, Türkiye, 25 - 29 Nisan 2009, ss.1, (Özet Bildiri)
299. A novel gene therapy strategy involving immune-modulation relinquished lymphocyte infiltration into islet grafted sites in STZ induced diabetic rats
11th European Congress of Endocrinology, İstanbul, Türkiye, 25 - 29 Nisan 2009, ss.1, (Özet Bildiri)
300. Comparative molecular analysis of TRAIL ligand and receptor expression profiles in cyclophosphamide versus streptozotocin-induced diabetes in non-obese diabetic (NOD) mice
11th European Congress of Endocrinology, İstanbul, Türkiye, 25 - 29 Nisan 2009, ss.336, (Tam Metin Bildiri)
301. BevacizumAb tedavisi uygulanan kolon kanserli hastalarda sTRAIL düzeyinin artışı sağ kalım süresi ile ilişkilidir
XVIII. Ulusal Kanser Kongresi, Antalya, Türkiye, 21 - 26 Nisan 2009, ss.410, (Tam Metin Bildiri)
308. Prolonged normoglycemia in STZ-induced diabetic rats transplanted with Adenovirus-mediated human TRAIL gene (Ad5hTRAIL) infected islets
16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1119-1120, (Özet Bildiri)
309. Pancreatic ductal adenocarcinoma (PDAC) patients reveal elevated TRAIL Death Receptor-4 (DR4) and decoy receptor-2 (DcR2) expression correlated with significant cell death
16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1104, (Özet Bildiri)
310. In vivo imaging to detect the duration of adenovirus mediated EGFP transgene expression in allogeneic islet grafts
16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1121-1122, (Özet Bildiri)
311. Soluble TRAIL concentrations in patients with rheumatoid arthritis
16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1149, (Özet Bildiri)
312. Clinical significance of TRAIL and its receptor expression profiles on CD4+CD25+Foxp3+Tregs and CD8+CD25+T cells in patients with rheumatoid arthritis
16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1148-1149, (Özet Bildiri)
319. Adenovirus-mediated human TRAIL gene (Ad5hTRAIL) delivery into pancreatic islets provides prolonged normoglycemia in STZ-induced diabetic rats
3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 - 01 Mayıs 2008, ss.10, (Özet Bildiri)
325. Gene therapy application scenarios to prolong islet-graft survival in patients with type 1 diabetes
3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.5, (Özet Bildiri)
326. Gene therapy mediated apoptosis inducing approaches employing Ad5hTRAIL and a DCR2 siRNA strategy in lung cancer patients
3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.3, (Özet Bildiri)
331. Gene therapy application scenarios to prolong islet-graft survival in patients with type 1 diabetes
3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.5, (Özet Bildiri)
332. Adenovirus-mediated human TRAIL gene (Ad5hTRAIL) delivery into pancreatic islets provides prolonged normoglycemia in STZ-induced diabetic rats
3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 - 01 Mayıs 2008, ss.10, (Özet Bildiri)
334. Tip 1 diyabet hastalarinda gerceklestirilen adacik naklinde graft sagkalimini uzatabilecek gen tedavi senaryolari
44. Ulusal Diyabet Kongresi, Antalya, Türkiye, 28 Mayıs - 01 Haziran 2008, ss.3, (Özet Bildiri)
336. Tip 1 diyabet hastalarinda gerceklestirilen adacik naklinde graft sagkalimini uzatabilecek gen tedavi senaryolari
44. Ulusal Diyabet Kongresi, Antalya, Türkiye, 28 Mayıs - 01 Haziran 2008, ss.3, (Özet Bildiri)
338. Pankreatik adaciklara adenovirus aracili insan TRAIL geni (Ad5hTRAIL) aktarimi STZ induklemeli diyabetik sicanlarda uzun sureli normoglisemi saglar
44. Ulusal Diyabet Kongresi, Antalya, Türkiye, 28 Mayıs - 01 Haziran 2008, ss.1, (Özet Bildiri)
340. Pankreatik adaciklara adenovirus aracili insan TRAIL geni (Ad5hTRAIL) aktarimi STZ induklemeli diyabetik sicanlarda uzun sureli normoglisemi saglar
44. Ulusal Diyabet Kongresi, Antalya, Türkiye, 28 Mayıs - 01 Haziran 2008, ss.1, (Özet Bildiri)
345. TRAILING from molecular diagnostics to prostate cancer gene therapy
XIX Ulusal İmmunoloji Kongresi, Antalya, Türkiye, 21 - 24 Kasım 2007, ss.33, (Özet Bildiri)
346. TRAILING from molecular diagnostics to prostate cancer gene therapy
XIX Ulusal İmmunoloji Kongresi, Antalya, Türkiye, 21 - 24 Kasım 2007, ss.33, (Özet Bildiri)
349. Comparative analysis of TRAIL and its receptor expression profiles in synoviocytes versus peripheral lymphocytes of patients with rheumatoid arthritis
15th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Rotterdam, Hollanda, 27 - 30 Ekim 2007, cilt.18, ss.1091-1092, (Özet Bildiri)
350. Adenovirus vectors efficiently deliver TRAIL into pancreatic islets without generating cytotoxic effects
15th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Rotterdam, Hollanda, 27 - 30 Ekim 2007, cilt.18, ss.1074, (Özet Bildiri)
351. High endogenous TRAIL expression levels in human pancreas is correlated with increased cell death
15th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Rotterdam, Hollanda, 27 - 30 Ekim 2007, cilt.18, ss.1074-1075, (Özet Bildiri)
352. . “Expression Profile of TRAIL and its Receptors in Breast Cancer patients with invasive ductal carcinoma’’ Vol. 5 (4), EJC Supement Elsevier, 2007.
14th European Cancer Conference, Barcelona, İspanya, 23 - 27 Eylül 2007, ss.2136, (Özet Bildiri)
353. Expression profile of TRAIL and its receptors in breast cancer patients with invasive ductal carcinoma
ECCO 14 The European Cancer Conference, Barcelona, İspanya, 23 - 27 Eylül 2007, ss.225-226, (Tam Metin Bildiri)
355. Tip 1 diyabet gelişiminde rol alan TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptörlerinin normal insan pankreasindaki sentez profili ve artan apoptozis ile korelasyonu
X. Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 6 - 09 Eylül 2007, ss.232, (Tam Metin Bildiri)
357. Tip 1 diyabet gelişiminde rol alan TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptörlerinin normal insan pankreasindaki sentez profili ve artan apoptozis ile korelasyonu
X. Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 6 - 09 Eylül 2007, ss.112, (Özet Bildiri)
358. Tip 1 diyabet gelişiminde rol alan TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptörlerinin normal insan pankreasindaki sentez profili ve artan apoptozis ile korelasyonu
X. Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 6 - 09 Eylül 2007, ss.112, (Özet Bildiri)
365. Tip 1 diyabetli hastalarda kullanılacak etkin bir tedavi modelinin geliştirilmesi maksadıyla pankreatik adacıklara adenovirus aracılı TRAİL geni aktarımı
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.51, (Tam Metin Bildiri)
366. Tip 1 diyabette ölümcül ligant aracılı gen tedavi modelinin moleküler etki mekanizması.
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.45, (Özet Bildiri)
367. Yokluğu Tip 1 diyabetle ilişkilendirilmis TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptorlerinin normal insan pankreasindaki sentez profili
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.54, (Özet Bildiri)
368. Yokluğu Tip 1 diyabetle ilişkilendirilmis TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptorlerinin normal insan pankreasindaki sentez profili
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.54, (Özet Bildiri)
369. Tip 1 diyabetli hastalarda kullanılacak etkin bir tedavi modelinin geliştirilmesi maksadıyla pankreatik adacıklara adenovirus aracılı TRAİL geni aktarımı
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.51, (Tam Metin Bildiri)
370. Tip 1 diyabette ölümcül ligant aracılı gen tedavi modelinin moleküler etki mekanizması.
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.45, (Özet Bildiri)
371. Yokluğu Tip 1 diyabetle ilişkilendirilmis TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptorlerinin normal insan pankreasindaki sentez profili
43. ULUSAL DİYABET KONGRESİ, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.66, (Tam Metin Bildiri)
374. A DcR2 siRNA strategy employing three different siRNA constructs in combination defeats adenovirus transferred TRAIL resistance in lung cancer cells
XIV Annual Congress of the European Society of Gene Therapy, Atina, Yunanistan, 9 - 12 Kasım 2006, ss.103, (Tam Metin Bildiri)
376. Upnormal increase in the nuclear NF-kB activity of the rat cavernosal tissue is correlated with diabetes related erectile dysfunction syndrome
XIV Annual Congress of the European Society of Gene Therapy, Atina, Yunanistan, 9 - 12 Kasım 2006, ss.213, (Tam Metin Bildiri)
380. Upnormal increase in the nuclear NF-kB activity of the rat cavernosal tissue is correlated with diabetes related erectile dysfunction syndrome
XIV Annual Congress of the European Society of Gene Therapy, Atina, Yunanistan, 9 - 12 Kasım 2006, ss.213, (Tam Metin Bildiri)
382. Adenovirus mediated TRAIL gene delivery as a model for the treatment of patients with diabetes
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.206, (Özet Bildiri)
383. Differential expression of trail and its receptors in patients with prostate carcinoma
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.133, (Özet Bildiri)
384. Adenovirus delivery of TRAIL effectively destroys synoviocytes of patients with rheumatoid arthritis
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.134, (Özet Bildiri)
385. A DCR2 siRNA approach defeats trail resistance in lung cancer cells
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.133, (Özet Bildiri)
386. Mechanism of TRAIL resistance in breast cancer cells for adenovirus mediated gene delivery
Annual Meeting of the American-Association-of-Immunologists, Massachusetts, Amerika Birleşik Devletleri, 12 - 16 Mayıs 2006, cilt.176, (Özet Bildiri)
390. Tip 1 diyabetli hastalar için geliştirilen pankreatik adacık transplantasyonunda adenovirus aracılı TRAİL gen transferinin etkinliği
IX. Ulusal Tıbbi Biyoloji Kongresi, Manisa, Türkiye, 24 - 27 Kasım 2005, ss.66, (Özet Bildiri)
391. Tip 1 diyabetli hastalar için geliştirilen pankreatik adacık transplantasyonunda adenovirus aracılı TRAİL gen transferinin etkinliği
IX. Ulusal Tıbbi Biyoloji Kongresi, Manisa, Türkiye, 24 - 27 Kasım 2005, ss.66, (Özet Bildiri)
394. DcR2 siRNA yaklaşımı A549 akciğer kanser hücrelerini adenovirus aracılı TRAİL transferine duyarlı kılar
IX. Ulusal Tıbbi Biyoloji Kongresi, Manisa, Türkiye, 24 - 27 Kasım 2005, ss.5, (Özet Bildiri)
398. A DcR2 siRNA approach overcomes TRAIL resistance in A549 lung cancer cells
13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.172, (Tam Metin Bildiri)
401. Adenovirus mediated NF-kB inhibiting strategies for the treatment of patients with type 1 diabetes
13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.88, (Tam Metin Bildiri)
402. TRAIL ligand and receptor expressions are differentially upregulated in prostate carcinoma patients: a significant issue for gene therapy of advanced prostate cancer
13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.22, (Tam Metin Bildiri)
404. Surface TRAIL decoy receptor-4 expression constitutes a resistance to adenovirus delivery of TRAIL in MCF7 breast cancer cells
13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.15, (Tam Metin Bildiri)
405. Efficient adenovirus mediated TRAIL gene delivery into pancreatic islets as a model for the treatment of patients with type 1 diabetes
13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.74, (Tam Metin Bildiri)
410. Surface TRAIL Receptor-4 expression correlates with TRAIL resistance in breast cancer cells
Advances in Molecular Medicine, İstanbul, Türkiye, 3 - 05 Eylül 2005, ss.164, (Tam Metin Bildiri)
412. Testing the efficacy of a novel adenovirus mediated TRAIL gene therapy approach for the treatment of patients with Type 1 Diabetes
Advances in Molecular Medicine, İstanbul, Türkiye, 3 - 05 Eylül 2005, ss.160, (Tam Metin Bildiri)
413. A novel death ligand mediated gene therapy approach for patients with lung cancer
Advances in Molecular Medicine, İstanbul, Türkiye, 3 - 05 Eylül 2005, ss.162, (Tam Metin Bildiri)
414. Surface TRAIL Receptor-4 expression correlates with TRAIL resistance in breast cancer cells
Advances in Molecular Medicine, İstanbul, Türkiye, 3 - 05 Eylül 2005, ss.164, (Tam Metin Bildiri)
417. Current Progress in Cancer Gene Therapy
XIX Ulusal Biyokimya Kongresi, Antalya, Türkiye, 22 - 25 Nisan 2005, ss.5, (Özet Bildiri)
418. Advanced prostate cancer cells display differential NF-kB activation pattern which is the primary determinant of TRAIL resistance
12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.19, (Tam Metin Bildiri)
419. Resistance to Adenovirus mediated TRAIL gene therapy in breast cancer cells is eliminated by the expression of dominant negative IKKb
12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.20, (Tam Metin Bildiri)
420. Therapeutic effect of recombinant adenovirus mediated TRAIL gene therapy method in Lung Cancer
12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.22, (Tam Metin Bildiri)
421. Advanced prostate cancer cells display differential NF-kB activation pattern which is the primary determinant of TRAIL resistance
12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.19, (Tam Metin Bildiri)
422. Anti HIV drug PDTC genetoxic agents synergistically activate Adeno Associated Virus Type-2 endocytosis and transduction
12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.56, (Tam Metin Bildiri)
425. Hücre içi anti-apoptotik yolun bloke edilmesi meme kanserini adenovirus aracılı TRAİL gen tedavi metoduna karşı duyarlı hale getirdi
1. Ulusal Klinik Pratikde Kök Hücre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 7 - 09 Mayıs 2004, ss.127, (Özet Bildiri)
426. Akciğer kanserinde recombinant adenovirus aracılı TRAİL gen tedavi metodunun terapötik etkisi
1. Ulusal Klinik Pratikde Kök Hücre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 7 - 09 Mayıs 2004, ss.128, (Özet Bildiri)
428. Akciğer kanserinde yeni bir adenovirus aracılı TNF-alpha gen tedavi metodu
VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2004, ss.8, (Özet Bildiri)
429. İleri ever prostat kanserinde NFkB yolunun bloke edilmesi TRAİL dirençliliğini kırar
VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2004, ss.27, (Özet Bildiri)
431. İleri ever meme kanserinin adenovirus aracılı TRAİL gen tedavi metoduna duyarlılaştırma yöntemleri
VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2004, ss.4, (Özet Bildiri)
432. İleri ever prostat kanserinde NFkB yolunun bloke edilmesi TRAİL dirençliliğini kırar
VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2004, ss.27, (Özet Bildiri)
437. Mesane kanser gelişiminde PTENin prognostik değerinin belirlenmesi
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.4, (Özet Bildiri)
438. Adenovirus aracılı TRAİL geni aktarımının prostat karsinomanın farklı evreleri üzerindeki etkinliği ve prostat kanserli hastalarda TRAİLe olan direnci kırmak için yeni gen tedavi metotlarının geliştirilmesi
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.3, (Özet Bildiri)
439. PTENin Gleson skoru ve PSAya kıyasla prostat kanserindeki prognostik değerinin belirlenmesi.
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.5, (Özet Bildiri)
440. PTENin Gleson skoru ve PSAya kıyasla prostat kanserindeki prognostik değerinin belirlenmesi.
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.5, (Özet Bildiri)
441. Adenovirus aracılı TRAİL geni aktarımının prostat karsinomanın farklı evreleri üzerindeki etkinliği ve prostat kanserli hastalarda TRAİLe olan direnci kırmak için yeni gen tedavi metotlarının geliştirilmesi
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.3, (Özet Bildiri)
442. Mesane kanser gelişiminde PTENin prognostik değerinin belirlenmesi
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.4, (Özet Bildiri)
444. Prostat kanserli olgularda PTEN ekspresyonunun prognostic değeri
XV. Ulusal Kanser Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2003, ss.559, (Özet Bildiri)
445. PTEN ekspresyon düzeyinin mesane kanseri gelişimindeki rolü
XV. Ulusal Kanser Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2003, ss.558, (Özet Bildiri)
446. PTEN ekspresyon düzeyinin mesane kanseri gelişimindeki rolü
XV. Ulusal Kanser Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2003, ss.558, (Özet Bildiri)
447. Prostat kanserli olgularda PTEN ekspresyonunun prognostic değeri
XV. Ulusal Kanser Kongresi, Antalya, Türkiye, 23 - 27 Nisan 2003, ss.559, (Özet Bildiri)
450. A new treatment modality for lung cancer; Differential regulation of Rac1 and IKK pathways sensitizes lung cancer cells to TNF mediated apoptosis
9th Annual Meeting of European Society of Gene Therapy, Antalya, Türkiye, 2 - 04 Kasım 2001, ss.149, (Özet Bildiri)
Kitaplar
4
4. Diyabet tedavisinde inkretin tabanlı gen tedavi stratejileri
Geçmişten Geleceğe Diabetes Mellitus, İmamoğlu Ş., Satman İ., Akalın S., Salman S., Yılmaz C., Editör, Türkiye Endokrinoloji Ve Metabolizma Der Yayınları, Ankara, ss.603-614, 2015
Metrikler
Yayın
566
Açık Erişim
27
BM Sürdürülebilir Kalkınma Amaçları
